written. Final diagnosis by medical specialists was
as follows: 41 were diagnosed with Alzheimer’s, 2
with vascular dementia and 5 with other diseases.
6 DISCUSSIONS
Community-based screening is a useful way to
detect persons with dementia in their early stages.
Several different tests were developed for the
purpose of screening dementia. The Mini-Mental
State Examination (MMSE) and the Hasegawa
dementia scale, which are basically based on face-
to-face interviews, are widely used to differentiate
between normal aged people and cases of dementia
in Japan. However, these tests were originally
designed to diagnose dementia, and are not suitable
for community-based settings because they take too
long and are too cumbersome to administer(David
and Jeffrey, 1999). A useful screening battery for
dementia needs to be brief, simple and accurate. In
this study, the primary screening program revealed
that overall sensitivity and specificity for screening
dementia was 96% and 86%, respectively, which
were equivalent to other studies (Mendiondo et al.,
2003), (Shulman, 2000), (Solomon et al., 1998).
When we develop a computer system whose main
target users are elderly persons, the system should be
easy to operate even by a person with slight mentally
debilitating disorders or without any type of
experience with a computer. Adopting a touch panel
display as an input device with the help of text
prompts and audio instructions could present an easy
user-computer interface and almost all of the
subjects could understand how to interact with the
system and completed the tasks by themselves. In
the actual screening procedure, we detected 55
persons with MCI and 74 persons as suspected of
suffering with dementia out of 998 elderly residents.
We believe that this computerized screening system
is useful for community-based settings and
contributes toward the early detection of persons
with dementia.
REFERENCES
Buschke H, Kuslansky G, Katz M, et al. Screening for
dementia with the Memory Impairment Screen.
Neurology 1999; 52: 231-238.
Barker WW, Luis C, Harwood D, et al. The effect of a
memory screening program on the early diagnosis of
Alzheimer disease. Alzheimer Dis Assoc Disord.
2005; 19: 1-7.
Knopman DS. Current treatment of mild cognitive
impairment and Alzheimer's disease. Curr Neurol
Neurosci Rep 2006; 6: 365-371.
Bennett DA, Schneider JA, Arvanitakis Z, et al.
Neuropathology of older persons without cognitive
impairment from two community-based studies.
Neurology 2006; 66: 1837-1844.
Ganguli M, Rodriguez E, Mulsant B, et al. Detection and
management of cognitive impairment in primary care:
The Steel valley Senior survey. J Am Geriatr Soc
2004; 52: 1668-1675.
Letz R, Green RC, Woodard JL. Development of a
computer-based battery designed to screen adults for
neuropsychological impairment. Neurotoxicol Teratol
1996; 18(4): 365-370.
Katho S, Shimogaki H, Onodera A, et al. Development of
the revised version of Hasegawa’s Dementia Scale,
Ronen Seishin Igaku Zasshi 1991; 2: 1339-1347. (in
Japanese)
Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, et al.
The Alzheimer's Disease Assessment Scale: patterns
and predictors of baseline cognitive performance in
multicenter Alzheimer's disease trials. Neurology.
1997;48(6):1511-1517.
American Psychiatric Association. Diagnostic and
statistical manual of mental disorders. 3rd ed, revised.
Washington, DC: American Psychiatric Association;
1987.
David RD, Jeffrey LC. Evaluating dementia screening
tests. Neurology 1999; 52: 224-227.
Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA.
Designing a Brief Alzheimer Screen (BAS). J
Alzheimers Dis 2003; 5: 391-398.
Shulman KI. Clock-drawing: is it the ideal cognitive
screening test? Int J Geriatr Psychiatry 2000; 15: 548-
561.
Solomon PR, Hirschoff A, Kelly B, et al. A 7 minute
neurocognitive screening battery highly sensitive to
Alzheimer's disease. Arch Neurol 1998; 55: 349-355.
HEALTHINF 2009 - International Conference on Health Informatics
404